Vancomycin tolerance in Gram-positive cocci

Miriam Moscoso1, Mirian Domenech, Ernesto García

  • 1Departamento de Microbiología Molecular y Biología de las Infecciones, Centro de Investigaciones Biológicas (CSIC) and CIBER de Enfermedades Respiratorias (CIBERES), Ramiro de Maeztu, 9, 28040 Madrid, Spain.

Insights

Vancomycin tolerance in bacteria is increasing, compromising this crucial antibiotic

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Vancomycin is a critical antibiotic for treating multi-resistant Gram-positive infections.
  • Emerging vancomycin resistance and tolerance in pathogens like enterococci, staphylococci, and streptococci threaten its clinical efficacy.
  • Understanding the molecular mechanisms of vancomycin tolerance is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To explore the molecular basis of vancomycin tolerance in key bacterial pathogens.
  • To identify potential pathways and factors contributing to reduced vancomycin susceptibility.

Main Methods:

  • Review of recent evidence on vancomycin tolerance mechanisms.
  • Analysis of studies investigating bacterial responses to vancomycin exposure.
  • Focus on molecular pathways including stringent response, autolysin activity, and two-component regulatory systems.

Main Results:

  • Vancomycin's bactericidal activity may involve superoxide anions in enterococci.
  • The stringent response contributes to vancomycin tolerance in Enterococcus faecalis.
  • Reduced autolysin activity and cell envelope stress-related two-component systems are implicated in vancomycin tolerance in Staphylococcus aureus and Streptococcus pneumoniae.

Conclusions:

  • Vancomycin tolerance is a complex phenomenon with varied molecular underpinnings across different bacterial species.
  • Further research is needed to fully elucidate the precise regulatory pathways involved in vancomycin tolerance.
  • Understanding these mechanisms is essential for combating antimicrobial resistance and preserving vancomycin's therapeutic value.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antibiotic Selection00:57

Antibiotic Selection

Overview